ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 16 Feb 2024
Last Applicant/ Owned by
69 Innovation Drive, Milton Park
Abingdon, Oxfordshire
GB
OX144RQ
Serial Number
97769288 filed on 26th Jan 2023
Registration Number
N/A
Correspondent Address
Melanie Howard
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
TUMOR-DIRECTED ONCOLYTIC IMMUNOTHERAPIES
Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for inducing immune response; pharmaceuticals; pharmaceuticals for the treatment of cancer; pharma Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid
Class [005]
Pharmaceutical Products
Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for inducing immune response; pharmaceuticals; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response; vaccines; immunotherapy products; gene therapy products; Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
Mark Details
Serial Number
No 97769288
Mark Type
No Service Mark
Attorney Docket Number
No 221834-00046
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 16th Feb 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 16th Feb 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 02th Nov 2023 | NON-FINAL ACTION WRITTEN |
| 02th Nov 2023 | NON-FINAL ACTION E-MAILED |
| 02th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 24th Oct 2023 | ASSIGNED TO EXAMINER |
| 15th Feb 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 30th Jan 2023 | NEW APPLICATION ENTERED |